Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Annals of Translational Medicine|March 17, 2020
RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAsPeng Kuang, Peixin Chen, Lei Wang, et al.
Oncotargets and Therapy|August 6, 2020
Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung CancerChenglong Sun, Liping Zhang, Wei Zhang, et al.
Vaccine|January 23, 2026
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsJoanne M Langley, Manish Sadarangani, Christian Ockenhouse, et al.
Influenza and Other Respiratory Viruses|September 7, 2022
Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary diseaseSunita Mulpuru, Melissa K Andrew, Lingyun Ye, et al.
Vaccine|December 18, 2019
Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I studyÉlodie Pastural, Shelly A McNeil, Donna MacKinnon-Cameron, et al.
Translational Lung Cancer Research|March 10, 2023
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring <i>BRAF</i> mutationsHaowei Wang, Lei Cheng, Chao Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2022
Characteristics of Notch signaling pathway and its correlation with immune microenvironment in SCLCWei Li, Lingyun Ye, Yan Huang, et al.
Vaccine|March 5, 2026
Adenovirus type 5 vector-based COVID-19 vaccine does not increase the likelihood of HIV infectionGuillermo M Ruiz-Palacios, Pedro Enrique Cahn, Scott A Halperin, et al.
Emerging Infectious Diseases|February 25, 2020
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada<sup>1</sup>Joanne M Langley, Soren Gantt, Caroline Quach, et al.
Vaccines|July 24, 2020
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of AgeJoanne Langley, Elodie Pastural, Scott Halperin, et al.
Pageof 8